Latest news
FDA Approves Labcorp Companion Diagnostic for Advanced Melanoma - Clinical Lab ProductsClinical Lab Products · Mon, 10 Aug 2026 19:06:57 GMTUS FDA Approves LabCorp’s Companion Diagnostic Test for Advanced Melanoma: Here’s What To Know - thedermdigest.comthedermdigest.com · Mon, 10 Aug 2026 18:14:33 GMTBiomarkers aid cost-benefit analysis of head and neck cancer immunotherapy - medicalxpress.commedicalxpress.com · Mon, 10 Aug 2026 17:00:04 GMTFDA Approves Labcorp's PGDx Elio Tissue Complete CDx for Advanced Melanoma - Dermatology TimesDermatology Times · Mon, 10 Aug 2026 15:10:24 GMTLabcorp nabs FDA green light for BRAF melanoma diagnostic - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 13:28:52 GMTLabcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMTFor advanced melanoma, Labcorp's test supports access to targeted therapies - Stock TitanStock Titan · Mon, 10 Aug 2026 11:00:00 GMTAkeso Doses First Patient in Phase II Trial of AK146D1–Ivonescimab Combination for Advanced Breast Cancer - BioPharma APACBioPharma APAC · Mon, 10 Aug 2026 04:37:45 GMT